To evaluate longer-term (5-7 years) outcomes of the twelve (12) subjects treated with AGN1 Femoral LOEP in the clinical study "A Prospective Pilot Evaluation of Percutaneous Osteo-supplementation in the Proximal Femur of Osteoporotic Patients". Performance will be evaluated via medical history evaluation, X-ray, DXA, CT and mobility testing. The study will look at the extent to which the benefits demonstrated in the initial, baseline study were sustained over time. In this manner, it may be possible to determine the rate of change in BMD following the treatment; thereby allowing prediction of the total benefit period. In addition, this longer period of observation allows for further evaluation of the safety profile of the material in osteoporosis patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bone Mineral Density
Timeframe: through study completion, an average of 30 days
Bone Mineral Density
Timeframe: through study completion, an average of 30 days
Bone Mineral Density
Timeframe: through study completion, an average of 30 days
Bone Mineral Density
Timeframe: through study completion, an average of 30 days
Bone Mineral Density
Timeframe: through study completion, an average of 30 days
Bone Mineral Density
Timeframe: through study completion, an average of 30 days
Bone Mineral Density
Timeframe: through study completion, an average of 30 days
Bone Mineral Density
Timeframe: through study completion, an average of 30 days
Bone Mineral Density
Timeframe: through study completion, an average of 30 days